{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:58:11Z","timestamp":1790935091856,"version":"4.1.0"},"reference-count":204,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtho.2026.104116","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:07:52Z","timestamp":1790932072000},"page":"104116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Pathology: Journal of Thoracic Oncology 20th Anniversary Series"],"prefix":"10.1016","volume":"21","author":[{"given":"William D.","family":"Travis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina K.","family":"Baine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Bubendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Dacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Galeteau-Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred R.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Maleszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pavlisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Rekhtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Roggli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipp","family":"Stroebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Sound","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2026.104116_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 Classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/JTO.0b013e318290868f","volume":"8","author":"Lindeman","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtho.2016.11.2228","article-title":"PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the Blueprint PD-L1 ihc assay comparison project","volume":"12","author":"Hirsch","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jtho.2018.05.013","article-title":"PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of Blueprint phase 2 project","volume":"13","author":"Tsao","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jtho.2016.03.025","article-title":"The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming Eighth Edition of the TNM classification of lung cancer","volume":"11","author":"Travis","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","article-title":"A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee","volume":"15","author":"Moreira","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jtho.2017.12.001","volume":"13","author":"Lindeman","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","article-title":"The International Association for the Study of Lung Cancer, Lung Cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer","volume":"11","author":"Nicholson","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jtho.2018.12.005","article-title":"Best practices recommendations for diagnostic immunohistochemistry in lung cancer","volume":"14","author":"Yatabe","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","article-title":"The 2015 World Health Organization classification of tumors of the thymus: continuity and changes","volume":"10","author":"Marx","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors?","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","article-title":"The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification","volume":"17","author":"Sauter","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jtho.2015.11.009","article-title":"The 2015 WHO classification of tumors of the heart and pericardium","volume":"11","author":"Burke","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2021.10.021","article-title":"The 2021 WHO classification of tumors of the heart","volume":"17","author":"Maleszewski","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib20","series-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"10.1016\/j.jtho.2026.104116_bib21","series-title":"World Health Organization of Tumours Editorial Board; WHO Classification of Thoracic Tumours","year":"2021"},{"key":"10.1016\/j.jtho.2026.104116_bib22","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#","article-title":"Small adenocarcinoma of the lung. Histologic characteristics and prognosis","volume":"75","author":"Noguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2026.104116_bib23","series-title":"Histological Typing of Lung and Pleural Tumors","author":"Travis","year":"1999"},{"key":"10.1016\/j.jtho.2026.104116_bib24","series-title":"World Health Organization, Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.jtho.2026.104116_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/PAS.0b013e31815cb162","article-title":"Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis","volume":"32","author":"Motoi","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib26","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2010.232","article-title":"Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage i cases","volume":"24","author":"Yoshizawa","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib27","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","article-title":"The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival","volume":"30","author":"Warth","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib28","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/JTO.0b013e318221f701","volume":"6","author":"Russell","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib29","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jtho.2019.07.008","article-title":"Expansion of the concept of micropapillary adenocarcinoma to include a newly recognized filigree pattern as well as the classical pattern based on 1468 stage I lung adenocarcinomas","volume":"14","author":"Emoto","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JTO.0000000000000486","article-title":"Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas","volume":"10","author":"Kadota","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jtho.2024.03.015","volume":"19","author":"Travis","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.5858\/arpa.2012-0264-RA","article-title":"Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification","volume":"137","author":"Travis","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2026.104116_bib33","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1158\/1078-0432.CCR-19-1700","article-title":"Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic approach","volume":"25","author":"Chang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104116_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100453","article-title":"Pathologic assessment and staging of multiple non-small cell lung carcinomas: a paradigm shift with the emerging role of molecular methods","volume":"37","author":"Chang","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jtho.2024.11.016","article-title":"Differentiating separate primary lung adenocarcinomas from intrapulmonary metastases with emphasis on pathological and molecular considerations: recommendations from the international association for the study of lung cancer pathology committee","volume":"20","author":"Chou","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtho.2023.09.275","article-title":"Genomic staging of multifocal lung squamous cell carcinomas is independent of the comprehensive morphologic assessment","volume":"19","author":"Dacic","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jtho.2022.11.026","article-title":"Defining morphologic features of invasion in pulmonary nonmucinous adenocarcinoma with lepidic growth: a proposal by the International Association for the Study of Lung Cancer Pathology Committee","volume":"18","author":"Thunnissen","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/JTO.0b013e31819667bd","article-title":"Preinvasive lesions of the bronchus","volume":"4","author":"Banerjee","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib39","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/JTO.0b013e318229189d","article-title":"Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients","volume":"6","author":"Takahashi","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib40","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/JTO.0000000000000253","article-title":"Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes","volume":"9","author":"Kadota","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jtho.2025.09.1761","article-title":"A grading system for resected invasive squamous cell carcinoma of the lung: a multi-institutional study by the IASLC pathology committee","volume":"21","author":"Mino-Kenudson","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib42","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JTO.0b013e31824cc334","article-title":"Genetic changes in squamous cell lung cancer: a review","volume":"7","author":"Heist","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib43","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/JTO.0b013e31826aed28","article-title":"FGFR1 amplification in squamous cell carcinoma of the lung","volume":"7","author":"Heist","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/JTO.0000000000000617","article-title":"Prognostic impact of immune microenvironment in lung squamous cell carcinoma: tumor-infiltrating CD10+ neutrophil\/CD20+ lymphocyte ratio as an independent prognostic factor","volume":"10","author":"Kadota","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/JTO.0b013e31824c9485","article-title":"ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma","volume":"7","author":"Chaft","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib46","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/JTO.0b013e3181e8f1aa","article-title":"Pulmonary pleomorphic carcinoma: diagnosis using small biopsy specimens","volume":"5","author":"Iwasaki","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/JTO.0b013e3181ce3e3c","article-title":"Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis","volume":"5","author":"Kaira","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib48","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jtho.2025.07.121","article-title":"Distinct clinicogenomic features and immunotherapy associations in pulmonary sarcomatoid carcinoma: a multicenter retrospective study","volume":"20","author":"Hong","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib49","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jtho.2016.04.020","article-title":"Deep sequencing analysis reveals that KRAS mutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma","volume":"11","author":"Lococo","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib50","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/JTO.0000000000000450","article-title":"Response to crizotinib and clinical outcome in ALK-rearranged pulmonary pleomorphic carcinoma","volume":"10","author":"Murakami","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib51","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jtho.2016.01.009","article-title":"Synergistic activation upon MET and ALK coamplification sustains targeted therapy in sarcomatoid carcinoma, a deadly subtype of lung cancer","volume":"11","author":"Pelosi","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/JTO.0b013e31817c925c","article-title":"Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma","volume":"3","author":"Aokage","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib53","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jtho.2025.08.021","article-title":"Immune checkpoint inhibitor monotherapy for patients with pulmonary sarcomatoid carcinoma-the optimal therapeutic strategy for this rare lung cancer subtype?","volume":"20","author":"Boland","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib54","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jtho.2017.03.005","article-title":"Pulmonary sarcomatoid carcinomas commonly harbor either potentially targetable genomic alterations or high tumor mutational burden as observed by comprehensive genomic profiling","volume":"12","author":"Schrock","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib56","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/JTO.0b013e3181a97da3","article-title":"Soft tissue sarcomas of the chest wall","volume":"4","author":"Tsukushi","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib57","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jtho.2018.05.040","article-title":"Comparison of risk stratification models to predict recurrence and survival in pleuropulmonary solitary fibrous tumor","volume":"13","author":"Reisenauer","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/JTO.0000000000000556","article-title":"Better prognostic models may result in improved patient selection for adjuvant therapies after complete resection of solitary fibrous tumors of the pleura","volume":"10","author":"Tapias","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jtho.2023.12.022","article-title":"Initial chemotherapy for locally advanced and metastatic nut carcinoma","volume":"19","author":"Luo","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib60","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jtho.2016.06.023","article-title":"Association between congenital lung malformations and lung tumors in children and adults: a systematic review","volume":"11","author":"Casagrande","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib61","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/JTO.0b013e3181d95ca5","article-title":"Giant alveolar adenoma causing severe dyspnoea","volume":"5","author":"Petrella","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/JTO.0b013e3182468d06","article-title":"Solitary papillomas of the lower airways: epidemiological, clinical, and therapeutic data during a 22-year period and review of the literature","volume":"7","author":"Tryfon","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jtho.2018.12.003","article-title":"Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond alk gene rearrangements","volume":"14","author":"Chang","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib64","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1097\/JTO.0000000000000574","article-title":"Pneumonectomy-sparing NSAID therapy for pulmonary inflammatory myofibroblastic tumor","volume":"10","author":"Ghani","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib65","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2026.104116_bib66","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jtho.2026.104116_bib67","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtho.2026.104116_bib68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2026.104116_bib69","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jtho.2026.104116_bib70","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO precision medicine working group","volume":"35","author":"Mosele","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2015.0071","article-title":"Non-small cell lung cancer, version 6.2015","volume":"13","author":"Ettinger","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtho.2026.104116_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jtho.2018.09.022","article-title":"Detection of minimal residual disease using CT-DNA in lung cancer: current evidence and future directions","volume":"14","author":"Chae","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/his.15080","article-title":"Molecular pathology of non-small cell carcinoma","volume":"84","author":"Yatabe","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2026.104116_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtho.2021.07.031","article-title":"Screening for lung cancer in individuals who never smoked: an International Association for the Study of Lung Cancer early detection and screening committee report","volume":"17","author":"Kerpel-Fronius","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jtho.2017.01.020","article-title":"A sensitive ALK immunohistochemistry companion diagnostic test identifies patients eligible for treatment with crizotinib","volume":"12","author":"Thorne-Nuzzo","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103899","article-title":"Emerging targeted therapies for her2-mutant NSCLC","volume":"21","author":"Del Rio","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib77","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jtho.2022.10.015","article-title":"MET alterations in NSCLC-current perspectives and future challenges","volume":"18","author":"Remon","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103711","article-title":"Targeting met in EGFR-mutated NSCLC","volume":"21","author":"Saw","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2025.12.080","article-title":"Trastuzumab deruxtecan in patients with HER-2-overexpressing NSCLC: results from part 1 of the open-label, multicenter, phase 1b Destiny Lung 03 Trial","volume":"21","author":"Planchard","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib80","doi-asserted-by":"crossref","first-page":"869","DOI":"10.17305\/bb.2026.13832","article-title":"A remarkable year for NSCLC: seven new FDA approvals in 2025 across molecular targets","volume":"26","author":"Tomi\u0107","year":"2026","journal-title":"Biomol Biomed"},{"key":"10.1016\/j.jtho.2026.104116_bib81","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib82","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jtho.2019.12.107","article-title":"PD-L1 testing for lung cancer in 2019: perspective from the IASLC pathology committee","volume":"15","author":"Lantuejoul","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib83","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.jtho.2016.06.006","article-title":"Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma","volume":"11","author":"Takada","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib84","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jtho.2022.09.109","article-title":"Predictive biomarkers for immunotherapy in lung cancer: perspective from the international association for the study of lung cancer pathology committee","volume":"17","author":"Mino-Kenudson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib85","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/JTO.0000000000000526","article-title":"Programmed death-ligand 1 immunohistochemistry in lung cancer: in what state is this art?","volume":"10","author":"Kerr","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jtho.2018.01.020","article-title":"The PD-L1 immunohistochemistry biomarker: two steps forward, one step back?","volume":"13","author":"Kerr","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41379-019-0327-4","article-title":"\u201cInterchangeability\u201d of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy","volume":"33","author":"Torlakovic","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib88","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jtho.2025.07.131","article-title":"Digital versus manual PD-L1 scoring in advanced NSCLC from the IMpower110 and IMpower150 trials","volume":"20","author":"Herbst","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib89","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jtho.2018.11.034","article-title":"Antibody-drug conjugates for the therapy of thoracic malignancies","volume":"14","author":"Xie","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib90","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.23.00013","article-title":"Antibody-drug conjugates in lung cancer: recent advances and implementing strategies","volume":"41","author":"Passaro","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib91","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtho.2025.08.014","article-title":"MTAP expression by immunohistochemistry: a novel biomarker in NSCLC","volume":"21","author":"Brune","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib92","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jtho.2020.05.019","article-title":"The promises and challenges of tumor mutation burden as an immunotherapy biomarker: a perspective from the International Association for the Study of Lung Cancer Pathology Committee","volume":"15","author":"Sholl","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib93","doi-asserted-by":"crossref","first-page":"668","DOI":"10.5858\/arpa.2012-0263-RA","article-title":"Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification","volume":"137","author":"Travis","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2026.104116_bib94","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0031-1272866","article-title":"Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing","volume":"32","author":"Travis","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jtho.2026.104116_bib95","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0007-2017","article-title":"Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens: Number 2 in the Series \u201cPathology for the clinician\u201d Edited by Peter Dorfm\u00fcller and Alberto Cavazza","volume":"26","author":"Bubendorf","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jtho.2026.104116_bib96","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/his.15078","article-title":"Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists","volume":"84","author":"Kerr","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2026.104116_bib97","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jtho.2022.02.013","article-title":"NSCLC subtyping in conventional cytology: results of the International Association for the Study of Lung Cancer Cytology Working Group survey to determine specific cytomorphologic criteria for adenocarcinoma and squamous cell carcinoma","volume":"17","author":"Jain","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000527580","article-title":"The World Health Organization reporting system for lung cytopathology","volume":"67","author":"Schmitt","year":"2023","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jtho.2026.104116_bib99","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cncy.22137","article-title":"Immunocytochemistry for predictive biomarker testing in lung cancer cytology","volume":"127","author":"Jain","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jtho.2026.104116_bib100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/cncy.22818","article-title":"The updated College of American Pathologists principles of analytic validation of immunohistochemical assays: a step forward for cytopathology","volume":"132","author":"Roy-Chowdhuri","year":"2024","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jtho.2026.104116_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.983102","article-title":"Tissue management in precision medicine: what the pathologist needs to know in the molecular era","volume":"9","author":"Souza da Silva","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jtho.2026.104116_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152249","article-title":"Challenges to the effectiveness of next-generation sequencing in formalin-fixed paraffin-embedded tumor samples for non-small cell lung cancer","volume":"69","author":"da Silveira Corr\u00eaa","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib103","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jtho.2024.03.010","article-title":"Evaluation of major pathologic response and pathologic complete response as surrogate end points for survival in randomized controlled trials of neoadjuvant immune checkpoint blockade in resectable in NSCLC","volume":"19","author":"Hines","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib104","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtho.2024.06.010","article-title":"Neoadjuvant and adjuvant treatments for early stage resectable NSCLC: consensus recommendations from the International Association for the Study of Lung Cancer","volume":"19","author":"Spicer","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib105","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jtho.2023.07.006","article-title":"Neoadjuvant targeted therapy in resectable NSCLC: current and future perspectives","volume":"18","author":"Lee","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib106","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jtho.2023.07.017","article-title":"International Association for the Study of Lung Cancer study of reproducibility in assessment of pathologic response in resected lung cancers after neoadjuvant therapy","volume":"18","author":"Dacic","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103953","article-title":"Machine learning assessment of pathologic response in lung cancer resections after neoadjuvant therapy\u2014IASLC MPR Project","author":"Dacic","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib108","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jtho.2023.12.010","article-title":"Artificial intelligence-powered assessment of pathologic response to neoadjuvant atezolizumab in patients with NSCLC: results from the LCMC3 study","volume":"19","author":"Dacic","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib109","doi-asserted-by":"crossref","first-page":"S600","DOI":"10.1016\/j.jtho.2025.09.1133","article-title":"IASLC mutidisciplinary recommendations for pathological response evaluation of resected lymph nodes after neoadjuvant therapy in NSCLC","volume":"20","author":"Berezowska","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103977","article-title":"IASLC update on classification of pulmonary neuroendocrine neoplasms","volume":"21","author":"Beasley","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib111","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib112","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JTO.0000000000000092","article-title":"Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice","volume":"9","author":"Pelosi","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib113","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jtho.2021.05.020","article-title":"Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice","volume":"16","author":"Derks","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib114","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jtho.2024.11.018","article-title":"Identification of defined molecular subgroups on the basis of immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids","volume":"20","author":"Leunissen","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtho.2016.12.004","article-title":"The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential diagnosis. An international reproducibility study in a demanding set of cases","volume":"12","author":"Thunnissen","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib116","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","article-title":"SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization","volume":"15","author":"Baine","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib117","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","article-title":"POU2F3 in SCLC: clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC","volume":"17","author":"Baine","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib118","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104116_bib119","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.jtho.2020.07.008","article-title":"The rare YAP1 subtype of SCLC revisited in a biobank of 39 circulating tumor cell patient derived explant models: a brief report","volume":"15","author":"Pearsall","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103730","article-title":"YAP1 defines an emergent, plastic population of relapsed small cell lung cancer","volume":"21","author":"Stewart","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.103726","article-title":"Antibody\u2013drug conjugates in SCLC: DLL3, B7-H3, TROP2, and beyond","volume":"21","author":"Monaca","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib122","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1158\/1078-0432.CCR-22-1115","article-title":"RB tumor suppressor in small cell lung cancer: combined genomic and IHC analysis with a description of a distinct RB-proficient subset","volume":"28","author":"Febres-Aldana","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104116_bib123","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1158\/2159-8290.CD-24-0286","article-title":"Chromothripsis-mediated small cell lung carcinoma","volume":"15","author":"Rekhtman","year":"2025","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2026.104116_bib124","doi-asserted-by":"crossref","first-page":"860","DOI":"10.21037\/tlcr.2020.02.13","article-title":"Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis","volume":"9","author":"Baine","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.jtho.2026.104116_bib125","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2026.104116_bib126","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRAS G12C inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2026.104116_bib127","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.resinv.2024.09.013","article-title":"Therapeutic effects of an alk inhibitor, brigatinib, on lung large cell neuroendocrine carcinoma with EML4-ALK fusion","volume":"62","author":"Suetsugu","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.jtho.2026.104116_bib128","article-title":"Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib129","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jtho.2016.12.019","article-title":"BAP1 is altered by copy number loss, mutation, and\/or loss of protein expression in more than 70% of malignant peritoneal mesotheliomas","volume":"12","author":"Leblay","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib130","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the International Mesothelioma Panel from the Mesopath Reference Center","volume":"13","author":"Galateau Salle","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib131","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jtho.2020.01.025","article-title":"Comprehensive molecular and pathologic evaluation of transitional mesothelioma assisted by deep learning approach: a multi-institutional study of the International Mesothelioma Panel from the Mesopath Reference Center","volume":"15","author":"Galateau Salle","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib132","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jtho.2019.08.2506","article-title":"EUROCAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach","volume":"15","author":"Nicholson","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib133","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the International Association for the Study of Lung Cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib134","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib135","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/JTO.0b013e3181a8c874","article-title":"Localized malignant pleural mesothelioma: report of two cases","volume":"4","author":"Tanzi","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib136","volume":"21","author":"Yang","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2026.01.003","article-title":"Moving beyond morphology: toward a morpho-molecular classification of pleural mesothelioma","volume":"21","author":"Drevet","year":"2026","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib138","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","article-title":"Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma","volume":"6","author":"Kadota","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib139","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41379-021-00900-z","article-title":"Molecular characterization of pleomorphic mesothelioma: a multi-institutional study","volume":"35","author":"Roy","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib140","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jtho.2018.07.002","article-title":"Pathologic grading of malignant pleural mesothelioma: an evidence-based proposal","volume":"13","author":"Pelosi","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib141","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jtho.2016.12.006","article-title":"Improving the accuracy of mesothelioma diagnosis in China","volume":"12","author":"Guo","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib142","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic bap1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib143","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","article-title":"BRCA1-associated protein 1 (bap1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study","volume":"11","author":"Righi","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib144","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jtho.2025.06.020","article-title":"Clinical and pathologic phenotyping of mesotheliomas developing in carriers of germline BAP1 mutations","volume":"20","author":"Carbone","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib145","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jtho.2023.05.028","article-title":"The role of germline mutations in thoracic malignancies: between myth and reality","volume":"18","author":"Farinea","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib146","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jtho.2019.11.011","article-title":"Anaplastic lymphoma kinase gene rearrangement in children and young adults with mesothelioma","volume":"15","author":"Mian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib147","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jtho.2020.03.014","article-title":"Malignant mesothelioma in situ: clinical and pathologic implications","volume":"15","author":"Churg","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib148","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtho.2017.02.013","article-title":"The immune microenvironment, genome-wide copy number aberrations, and survival in mesothelioma","volume":"12","author":"Thapa","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib149","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtho.2017.09.1968","article-title":"Molecular and histopathological characterization of the tumor immune microenvironment in advanced stage of malignant pleural mesothelioma","volume":"13","author":"Patil","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib150","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jtho.2019.03.029","article-title":"Potential diagnostic and prognostic role of microenvironment in malignant pleural mesothelioma","volume":"14","author":"Salaroglio","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib151","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jtho.2023.11.017","article-title":"The interplay between the immune system, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy","volume":"19","author":"Nel","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib152","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2026.104116_bib153","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13073-022-01060-8","article-title":"Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma","volume":"14","author":"Creaney","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.jtho.2026.104116_bib154","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2026.104116_bib155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41698-024-00518-9","article-title":"EORTC-SPECTRA ARCAGEN study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers","volume":"8","author":"Tagliamento","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103644","article-title":"Update on gene fusions and the emerging clinicopathological landscape of peritoneal and pleural mesotheliomas and other neoplasms","volume":"9","author":"Benzerdjeb","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.jtho.2026.104116_bib157","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/PAS.0000000000000864","article-title":"A subset of malignant mesotheliomas in young adults are associated with recurrent ewsr1\/fus-atf1 fusions","volume":"41","author":"Desmeules","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib158","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jtho.2025.06.018","article-title":"Immune composition and immunotherapy outcomes of mesothelioma with BAP1, CKKN2a, MTAP, and NF2 alterations","volume":"20","author":"Dagogo-Jack","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib159","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.5858\/arpa.2023-0213-RA","article-title":"Molecular and immunohistochemical testing in mesothelioma and other mesothelial lesions","volume":"148","author":"Hung","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtho.2026.104116_bib160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"Bap1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and mbaits","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtho.2026.104116_bib161","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-020-0265-y","article-title":"Tumour predisposition and cancer syndromes as models to study gene-environment interactions","volume":"20","author":"Carbone","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtho.2026.104116_bib162","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtho.2026.104116_bib163","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s42003-022-04002-7","article-title":"Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice","volume":"5","author":"Giorgetti","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.jtho.2026.104116_bib164","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jtho.2022.08.008","article-title":"A knock-in mouse model of thymoma with the GTF2I l424h mutation","volume":"17","author":"He","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.104116_bib166","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/JTO.0000000000000397","article-title":"Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis","volume":"10","author":"Moreira","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.92","article-title":"Copy number aberrations of BCL2 and CDKN2a\/b identified by array-CGH in thymic epithelial tumors","volume":"3","author":"Petrini","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtho.2026.104116_bib168","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2026.104116_bib169","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jtho.2021.02.008","article-title":"A tuft cell-like signature is highly prevalent in thymic squamous cell carcinoma and delineates new molecular subsets among the major lung cancer histotypes","volume":"16","author":"Yamada","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100674","article-title":"Analysis of ASCL1\/NEUROD1\/POU2F3\/YAP1 yields novel insights for the diagnosis of olfactory neuroblastoma and identifies sinonasal tuft cell-like carcinoma","volume":"38","author":"Febres-Aldana","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib171","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtho.2015.09.001","article-title":"Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations","volume":"11","author":"Hwang","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib172","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JTO.0000000000000154","article-title":"ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting","volume":"9","author":"Marx","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib173","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jtho.2022.01.021","article-title":"Thymic carcinomas-a concise multidisciplinary update on recent developments from the thymic carcinoma working group of the International Thymic Malignancy Interest Group","volume":"17","author":"Roden","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib174","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/JTO.0000000000000296","article-title":"A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria","volume":"9","author":"Benveniste","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib175","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/JTO.0000000000000269","article-title":"Development of the International Thymic Malignancy Interest Group international database: an unprecedented resource for the study of a rare group of tumors","volume":"9","author":"Huang","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib176","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jtho.2023.07.008","article-title":"The International Association for the Study of Lung Cancer thymic epithelial tumors staging project: an overview of the central database informing revision of the forthcoming (ninth) edition of the TNM classification of malignant tumors","volume":"18","author":"Rimner","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib177","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/JTO.0000000000000393","article-title":"The impact of thymoma histotype on prognosis in a worldwide database","volume":"10","author":"Weis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib178","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2023.09.002","article-title":"The International Association for the Study of Lung Cancer thymic epithelial tumors staging project: proposal for a stage classification for the forthcoming (ninth) edition of the TNM classification of malignant tumors","volume":"18","author":"Ruffini","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib179","doi-asserted-by":"crossref","first-page":"255","DOI":"10.6004\/jnccn.2025.0027","article-title":"Thymomas and thymic carcinomas, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Riely","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtho.2026.104116_bib180","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jtho.2022.08.007","article-title":"Surgical, radiation, and systemic treatments of patients with thymic epithelial tumors: a clinical practice guideline","volume":"17","author":"Falkson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib181","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jtho.2023.09.001","volume":"18","author":"Marom","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib182","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jtho.2023.08.024","article-title":"The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: proposal for the T component for the forthcoming (ninth) edition of the TNM classification of malignant tumors","volume":"18","author":"Okumura","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib183","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jtho.2017.06.072","article-title":"Assessment of the itmig statement on the WHO histological classification and of the Eighth TNM staging of thymic epithelial tumors of a series of 188 thymic epithelial tumors","volume":"12","author":"Meurgey","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib184","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/d41586-018-06751-0","article-title":"Cancer immunologists scoop medicine Nobel prize","volume":"562","author":"Ledford","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2026.104116_bib185","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jtho.2018.04.013","article-title":"Expression patterns, prognostic value, and intratumoral heterogeneity of PD-L1 and PD-1 in thymoma and thymic carcinoma","volume":"13","author":"Owen","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib186","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic syndromes and thymic malignancies: an examination of the International Thymic Malignancy Interest Group retrospective database","volume":"13","author":"Padda","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib187","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jtho.2019.04.015","article-title":"Molecular classification of neuroendocrine tumors of the thymus","volume":"14","author":"Dinter","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib188","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/JTO.0000000000000660","article-title":"Impact of positive nodal metastases in patients with thymic carcinoma and thymic neuroendocrine tumors","volume":"10","author":"Weksler","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib189","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jtho.2025.04.013","article-title":"Characterization, prognosis, and treatment of patients with locally advanced or metastatic thymic neuroendocrine tumor: A retrospective study of the French GTE, ENDOCAN RENATEN, and RYTHMIC networks","volume":"20","author":"Fodil-Cherif","year":"2025","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib190","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1530\/ERC-20-0036","article-title":"Neuroendocrine neoplasm update: toward universal nomenclature","volume":"27","author":"Rindi","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jtho.2026.104116_bib191","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/JTO.0000000000000377","article-title":"A high-grade pleomorphic sarcoma in left atrium","volume":"10","author":"Zhu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib192","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/JTO.0b013e3181e59a91","article-title":"Cardiac sarcomas: an update","volume":"5","author":"Orlandi","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.104116_bib193","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/PAS.0000000000000202","article-title":"PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors","volume":"38","author":"Maleszewski","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib194","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.jacc.2015.03.569","article-title":"Prognostic and bioepidemiologic implications of papillary fibroelastomas","volume":"65","author":"Tamin","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtho.2026.104116_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2025.107800","article-title":"Characterization of the clinical, histopathologic, and immunohistochemical features of large papillary fibroelastomas and their S100-expressing spindle cell component and its potential relationship to cardiac valvular interstitial cells","volume":"81","author":"Casimero","year":"2026","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib196","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2350\/10-05-0826-OA.1","article-title":"Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: analyzing material from the hc registry","volume":"14","author":"Shehata","year":"2011","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib197","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAS.0000000000001448","article-title":"KRAS mutations in papillary fibroelastomas: a study of 50 cases with etiologic and diagnostic implications","volume":"44","author":"Bois","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib198","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.humpath.2014.05.003","article-title":"Benign lipomatous masses of the heart: a comprehensive series of 47 cases with cytogenetic evaluation","volume":"45","author":"Bois","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib199","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humpath.2016.10.014","article-title":"Cardiac angiosarcoma: histopathologic, immunohistochemical, and cytogenetic analysis of 10 cases","volume":"60","author":"Leduc","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/PAS.0000000000000184","article-title":"Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas","volume":"38","author":"Neuville","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib201","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/PAS.0000000000000275","article-title":"Cardiac sarcoma with MDM2 amplification","volume":"38","author":"Neuville","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2022.02.006","article-title":"Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets","volume":"123","author":"Cui","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib203","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41379-021-00874-y","article-title":"Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature","volume":"34","author":"Koelsche","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2026.104116_bib204","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/PAS.0000000000000271","article-title":"Do \u201cintimal\u201d sarcomas of the heart exist?","volume":"38","author":"Maleszewski","year":"2014","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426005691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086426005691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:39:58Z","timestamp":1790933998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086426005691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":204,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1556086426005691"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104116","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Pathology: Journal of Thoracic Oncology 20th Anniversary Series","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2026.104116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"104116"}}